Home › Funds › Citigroup Inc › DNLI
Citigroup Inc position in DNLI
DENALI THERAPEUTICS INC · Health Care
Latest position (Q2 2026)487.28K sh
Reported value held$12.53M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 109.03K | $5.50M | New |
| Q4 2021 | 120.38K | $5.37M | Add |
| Q1 2022 | 35.38K | $1.14M | Reduce |
| Q2 2022 | 111.81K | $3.29M | Add |
| Q3 2022 | 192.64K | $5.91M | Add |
| Q4 2022 | 128.12K | $3.56M | Reduce |
| Q1 2023 | 208.34K | $4.80M | Add |
| Q2 2023 | 108.03K | $3.19M | Reduce |
| Q3 2023 | 138.31K | $2.85M | Add |
| Q4 2023 | 141.28K | $3.03M | Add |
| Q1 2024 | 382.42K | $7.85M | Add |
| Q2 2024 | 104.45K | $2.43M | Reduce |
| Q3 2024 | 94.71K | $2.76M | Reduce |
| Q4 2024 | 166.71K | $3.40M | Add |
| Q1 2025 | 194.00K | $2.64M | Add |
| Q2 2025 | 76.31K | $1.07M | Reduce |
| Q3 2025 | 14.94K | $216.87K | Reduce |
| Q4 2025 | 30.95K | $510.90K | Add |
| Q1 2026 | 99.28K | $1.91M | Add |
| Q2 2026 | 487.28K | $12.53M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding DNLI
- BlackRock Inc 14.03M sh · $360.76M · Q2 2026
- Baillie Gifford & Co 11.96M sh · $307.62M · Q2 2026
- Vanguard Group 13.06M sh · $215.59M · Q4 2025
- Temasek Holdings 7.01M sh · $180.37M · Q2 2026
- Fidelity Management & Research (FMR) 4.54M sh · $116.66M · Q2 2026
- Goldman Sachs Group 4.16M sh · $106.89M · Q2 2026
- Geode Capital Management 3.97M sh · $102.21M · Q2 2026
- UBS Group AG 3.12M sh · $80.26M · Q2 2026
- Norges Bank Investment Management 2.82M sh · $72.65M · Q2 2026
- Capital Research Global Investors 2.57M sh · $65.99M · Q2 2026
- Casdin Capital 2.04M sh · $52.60M · Q2 2026
- Principal Global Investors 1.42M sh · $36.52M · Q2 2026